Eculizumab effectively reduced MG-ADL scores and corticosteroid use in thymoma-associated myasthenia gravis patients by week 12. The monoclonal antibody targets complement protein C5, preventing ...

Only drugs with inpatient-applicable REMS requirements were included in ... darbepoetin alfa, eculizumab, eltrombopag, epoetin alfa, lenalidomide, olanzapine extended-release injection, oxycodone ...